Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Liver Function”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06092333
What this trial is testing

VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50
Early research (Phase 1)Study completedNCT01012284
What this trial is testing

TMC207 in Patients With Moderately Impaired Hepatic Function

Who this might be right for
Moderate Hepatic Impairment
Tibotec BVBA 16
Not applicableLooking for participantsNCT07707830
What this trial is testing

Internal Organ and Musculoskeletal Assessment in Hypothyroidism (HYPOMORPH)

Who this might be right for
Hypothyroidism
Andijan State Medical Institute 500
Not applicableUnknownNCT04705194
What this trial is testing

Hepatectomy Risk Assessment With Functional Magnetic Resonance Imaging

Who this might be right for
HepatectomyLiver FailureLiver Cancer+1 more
University of Leeds 134
Early research (Phase 1)Study completedNCT00736905
What this trial is testing

TMC278-TiDP6-C130: Pharmacokinetics, Safety and Tolerability of TMC278 in Subjects With Mildly or Moderately Impaired Hepatic Function.

Who this might be right for
HIVAIDSHepatic Impairment
Tibotec Pharmaceuticals, Ireland 32
Early research (Phase 1)Study completedNCT06692322
What this trial is testing

Test How Zongertinib is Taken up in the Blood of People With and Without Liver Problems

Who this might be right for
Liver DiseasesHealthy
Boehringer Ingelheim 29
Not applicableNot Yet RecruitingNCT07056270
What this trial is testing

Development of a Set of Auxiliary Decision-making System for the Perioperative Period of Hepatectomy Based on Static CT and Artificial Intelligence.

Who this might be right for
Liver CirrhosisLiver Cancer
Tongji Hospital 500
Early research (Phase 1)Study completedNCT02161770
What this trial is testing

Study to Assess the Blood Levels and Safety of AZD9291 in Patients With Advanced Solid Tumours and Normal Liver Function or Mild or Moderate Liver Impairment

Who this might be right for
Solid Tumours
AstraZeneca 30
Not applicableUnknownNCT00283972
What this trial is testing

LAP-BAND Observational Cohort

Who this might be right for
Epworth Sleepiness ScaleGlycemic ControlLiver Function+4 more
Inamed 240
Not applicableStudy completedNCT03601845
What this trial is testing

MRE-IA in Liver Disease and Neurovascular Imaging

Who this might be right for
Diffuse and Focal Liver Diseases, Cerebral Function
Université de Sherbrooke 59
Testing effectiveness (Phase 2)Study completedNCT02115373
What this trial is testing

C-Met Second-Line Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Merck KGaA, Darmstadt, Germany 66
Early research (Phase 1)Study completedNCT06908954
What this trial is testing

The Blood Levels of Palovarotene in Participants With Abnormal Liver Function Compared to Healthy Adult Participants After Intake of a Single Dose

Who this might be right for
Hepatic ImpairmentHealthy
Ipsen 31
Early research (Phase 1)Study completedNCT03627754
What this trial is testing

Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Glasdegib

Who this might be right for
Hepatic Impairment
Pfizer 24
Early research (Phase 1)Study completedNCT00969813
What this trial is testing

A Safety and Tolerability Study of CP-690,550 in Subjects With Hepatic Impairment and Normal Hepatic Function

Who this might be right for
Hepatic Insufficiency
Pfizer 18
Early research (Phase 1)Study completedNCT02894385
What this trial is testing

Effect of Hepatic and Renal Impairment on the Pharmacokinetics, Safety and Tolerability of BAY1841788 (ODM-201)

Who this might be right for
PharmacokineticsHepatic InsufficiencyRenal Insufficiency
Bayer 29
Not applicableStudy completedNCT00825617
What this trial is testing

Quantitative Liver Functions in Turner Syndrome With and Without Hormone Replacement Therapy

Who this might be right for
Turner Syndrome
University of Aarhus 16
Large-scale testing (Phase 3)UnknownNCT03578055
What this trial is testing

BDD With UDCA Therapy After Laparoscopic Cholecystectomy

Who this might be right for
Cholecystitis, AcuteCholecystitis, Chronic
Ewha Womans University Mokdong Hospital 172
Early research (Phase 1)Looking for participantsNCT07519135
What this trial is testing

Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function

Who this might be right for
Healthy
Pfizer 26
Early research (Phase 1)Study completedNCT05283915
What this trial is testing

Study to Assess the Plasma Concentration of Tolebrutinib Given as a Tablet to Adult Participants With Mild Hepatic Impairment Compared to Participants With Normal Hepatic Function

Who this might be right for
Hepatic Function Abnormal
Sanofi 10
Early research (Phase 1)Study completedNCT05517525
What this trial is testing

Evaluate the Pharmacokinetics (PK) and Safety of a Single Dose of Brensocatib in Participants With Normal Hepatic Function and Participants With Hepatic Impairment

Who this might be right for
Hepatic Impairment
Insmed Incorporated 30
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation